Skip to main content

The broadestparasite coverage available in an isoxazoline endectocide targeting 7 types of parasites§ in one dose


Based on label comparison of the number of parasite types covered in an isoxazoline endectocide.


§Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel) protects dogs against ticks, fleas, heartworm disease, roundworms, hookworms, and tapeworms. Credelio Quattro-CA1 is conditionally approved for the treatment of New World screwworm larvae infestations in dogs pending a full demonstration of effectiveness.


Why Choose Credelio Quattro/Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel)?

  • Credelio Quattro first and only monthly chewable with broadest parasite protection

    The first and only isoxazoline endectocide to cover your canine patients against ticks, fleas, heartworm disease, roundworms, hookworms, New World screwworm, and 3 species of tapeworms

  • Heartworm Icon - Credelio Quattro is 100% effective

    In laboratory studies, Credelio Quattro was 100% effective against heartworm disease from the first monthly dose

  • Stopwatch icon - Credelio Quattro kills ticks faster than competitors

    In two head-to-head studies, lotilaner, the active ingredient in Credelio Quattro, killed ticks* faster** than sarolaner in Simparica Trio® and afoxolaner in NexGard® at the beginning of the month and at the end of the dosing period1,2

  • Credelio Logo

    Contains the same established dose of lotilaner used in Credelio

  • Lyme tick icon

    Prevents Lyme disease transmission as a direct result of killing black-legged ticks

  • Shield Icon

    Backed by Elanco’s Canine Parasiticides Satisfaction Guarantee

Credelio Quattro protects dogs against ticks, fleas, heartworm disease, roundworms, hookworms and tapeworms. Credelio Quattro-CA1 is conditionally approved for the treatment of New World screwworm larvae infestations in dogs pending a full demonstration of effectiveness

*A. americanum and I. scapularis

**Based on the time to statistical significance vs. control in two separate head-to-head studies

Dogs in a laboratory study treated with Credelio Quattro were protected from Borrelia burgdorferi infections, as a direct result of killing Ixodes scapularis ticks

Credelio Quattro/Credelio Quattro-CA1 Dosing and Administration

  • Checkmark

    A tasty beef-flavored meat allergen-free chewable tablet crafted for sensitive dogs3

  • Checkmark

    Administration with food or within 30 minutes of a meal

  • Checkmark

    Administer year-round to dogs and puppies 8 weeks of age and older and 3.3 pounds or greater

Credelio Quattro/Credelio Quattro-CA1 is available in 5 different weight bands making it suitable for dogs weighing 3.3 lbs. and above.

Tablet sizes

Not actual size.

Resources

Frequently Asked Questions

Indications: Credelio Quattro is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections.  Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick),  Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Borrelia burgdorferi infections (also known as Lyme disease) as a direct result of killing Ixodes scapularis vector ticks.

Credelio Quattro-CA1 is conditionally approved for the treatment of infestations caused by New World screwworm (NWS; Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.

Important Safety Information: Lotilaner, an ingredient in Credelio Quattro/Credelio Quattro-CA1, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro/Credelio Quattro-CA1 administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.

Credelio Quattro-CA1 is conditionally approved by the FDA pending a full demonstration of effectiveness under application number 141-619. Treatment of NWS myiasis includes removal of the larvae, lesion cleaning and surgical debridement. Implement appropriate wound care and pain management.

For full prescribing information, see the Credelio Quattro/Credelio Quattro-CA1 package insert.


Credelio CAT

Indications: Credelio® CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) for one month in cats and kittens 8 weeks of age and older and weighing 2.0 lbs or greater.

Credelio® CAT is also indicated for treatment and control of Ixodes scapularis (black-legged tick) infestations for one month in cats and kittens 6 months of age and older and weighing 2.0 lbs or greater.

Important Safety Information: Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. The safety of Credelio® CAT has not been established in breeding, pregnant and lactating cats. The effectiveness of Credelio® CAT against Ixodes scapularis in kittens less than 6 months of age has not been evaluated. The most frequently reported adverse reactions are weight loss, tachypnea and vomiting. For full prescribing information see the Credelio® CAT package insert.


Credelio

Indications: Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick) Rhipicephalus sanguineus (brown dog tick) and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older and weighing 4.4 pounds or greater. Credelio is indicated for the prevention of Borrelia burgdorferi infections (also known as Lyme disease) as a direct result of killing Ixodes scapularis vector ticks.

Important Safety Information: Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, polyuria, and diarrhea.  For full prescribing information see Credelio package insert.


About Elanco

Learn why we're a leading provider of innovative solutions that protect and enhance animal health.

Connect with Elanco

Credelio Quattro, Credelio, Elanco and diagonal bar logo are trademarks of Elanco or its affiliates. All other company and product names are trademarks of their respective owners. PM-US-24-2521(7)

© 2026 Elanco or its affiliates.